The Nikkei has featured the “Commercialization Demonstration Project for Integrated Manufacturing in India from Scintillators to PET Systems.” This project is being carried out with support from the Japan International Cooperation Agency (JICA) under the FY2025 Small and Medium Enterprise (SME) and SDGs Business Support Program (JICA Biz) – Commercialization Demonstration Project. The product handled by our company in this project is a PET (Positron Emission Tomography) system, a medical device capable of imaging the location and size of cancer within approximately 30 minutes and highly effective for early diagnosis. The project aims to expand the utilization of this technology. By establishing integrated manufacturing of all key PET components—from scintillator crystals, the most critical and costly component of PET systems, to electronic circuits, mechanical parts, and software—we will combine Japan’s advanced technology with India’s cost-efficient manufacturing capabilities. As a result, PET systems, which have not previously been manufactured domestically in India, will be produced locally at high performance and affordable prices. Their widespread adoption is expected to increase access to cancer diagnosis regardless of rural or urban location, income level, or gender, thereby promoting early detection and early treatment. In addition, as cancer incidence continues to rise among the working-age population, the widespread availability of affordable, India-made PET systems is expected to improve return-to-work rates through earlier diagnosis. This could help prevent long-term medical leave and workforce attrition, while also reducing talent losses for companies and lowering broader social costs.